Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
International Journal of Biological Macromolecules
|
June 30, 2024
Expression and characterization of scFv-6009FV in Pichia pastoris with improved ability to neutralize the neurotoxin Cn2 from Centruroides noxius
Mariel Adame, Hilda Vázquez, Daniel Juárez-López, et al.
Current Medicinal Chemistry
|
September 9, 2022
The Resilience of <i>Pseudomonas aeruginosa</i> to Antibiotics and the Designing of Antimicrobial Peptides to Overcome Microbial Resistance
Daniel Juárez-López, Estefanía Morales-Ruiz, Leonardo D Herrera-Zúñiga, et al.
Archives of Medical Research
|
February 26, 2020
In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells
Alejandro Schcolnik-Cabrera, Mandy Juárez, Bernardo Oldak, et al.
Oncology Letters
|
August 13, 2020
The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
Alejandro Schcolnik-Cabrera, Alma Chavez-Blanco, Guadalupe Dominguez-Gomez, et al.
Oncology Letters
|
March 21, 2020
Erratum: A combination of inhibitors of glycolysis, glutaminolysis and <i>de novo</i> fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
Alejandro Schcolnik-Cabrera, Guadalupe Dominguez-Gómez, Alma Chávez-Blanco, et al.
Oncology Letters
|
December 3, 2019
A combination of inhibitors of glycolysis, glutaminolysis and <i>de novo</i> fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
Alejandro Schcolnik-Cabrera, Guadalupe Dominguez-Gómez, Alma Chávez-Blanco, et al.
Hematology (Amsterdam, Netherlands)
|
August 23, 2014
Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience
Alejandro Schcolnik-Cabrera, Nancy Labastida-Mercado, Laura Samantha Galindo-Becerra, et al.
Expert Opinion on Investigational Drugs
|
May 4, 2018
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
Alejandro Schcolnik-Cabrera, Alma Chávez-Blanco, Guadalupe Domínguez-Gómez, et al.
Medical Oncology (Northwood, London, England)
|
July 23, 2025
Epigenetic reprogramming of mast and cancer cells modifies tumor-promoting cytokine networks
Alejandro Schcolnik-Cabrera, Marisol Ramírez-Yautentzi, Rodolfo Soria-Castro, et al.
Journal of Immunology Research
|
April 20, 2019
Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
Rodolfo Soria-Castro, Alejandro Schcolnik-Cabrera, Gloria Rodríguez-López, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
International Journal of Biological Macromolecules
|
June 30, 2024
Expression and characterization of scFv-6009FV in Pichia pastoris with improved ability to neutralize the neurotoxin Cn2 from Centruroides noxius
Mariel Adame, Hilda Vázquez, Daniel Juárez-López, et al.
Current Medicinal Chemistry
|
September 9, 2022
The Resilience of <i>Pseudomonas aeruginosa</i> to Antibiotics and the Designing of Antimicrobial Peptides to Overcome Microbial Resistance
Daniel Juárez-López, Estefanía Morales-Ruiz, Leonardo D Herrera-Zúñiga, et al.
Archives of Medical Research
|
February 26, 2020
In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells
Alejandro Schcolnik-Cabrera, Mandy Juárez, Bernardo Oldak, et al.
Oncology Letters
|
August 13, 2020
The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
Alejandro Schcolnik-Cabrera, Alma Chavez-Blanco, Guadalupe Dominguez-Gomez, et al.
Oncology Letters
|
March 21, 2020
Erratum: A combination of inhibitors of glycolysis, glutaminolysis and <i>de novo</i> fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
Alejandro Schcolnik-Cabrera, Guadalupe Dominguez-Gómez, Alma Chávez-Blanco, et al.
Oncology Letters
|
December 3, 2019
A combination of inhibitors of glycolysis, glutaminolysis and <i>de novo</i> fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
Alejandro Schcolnik-Cabrera, Guadalupe Dominguez-Gómez, Alma Chávez-Blanco, et al.
Hematology (Amsterdam, Netherlands)
|
August 23, 2014
Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience
Alejandro Schcolnik-Cabrera, Nancy Labastida-Mercado, Laura Samantha Galindo-Becerra, et al.
Expert Opinion on Investigational Drugs
|
May 4, 2018
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
Alejandro Schcolnik-Cabrera, Alma Chávez-Blanco, Guadalupe Domínguez-Gómez, et al.
Medical Oncology (Northwood, London, England)
|
July 23, 2025
Epigenetic reprogramming of mast and cancer cells modifies tumor-promoting cytokine networks
Alejandro Schcolnik-Cabrera, Marisol Ramírez-Yautentzi, Rodolfo Soria-Castro, et al.
Journal of Immunology Research
|
April 20, 2019
Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
Rodolfo Soria-Castro, Alejandro Schcolnik-Cabrera, Gloria Rodríguez-López, et al.
Page
of 5